Solasia Pharma K.K. (FRA:9SO)

Solasia Pharma K.K. Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,387	886	728	803	714
Cash & Short-Term Investments	1,387	886	728	803	714
Cash Growth	56.55%	21.70%	-9.34%	12.46%	-75.91%
Receivables	374	232	67	572	126
Inventory	112	128	122	14	-
Prepaid Expenses	-	17	57	43	48
Other Current Assets	17	3	2	3	6
Total Current Assets	1,890	1,266	976	1,435	894
Property, Plant & Equipment	113	47	81	63	120
Long-Term Investments	-	47	52	60	49
Other Intangible Assets	-	-	1,117	1,570	2,079
Other Long-Term Assets	142	2	3	6	2
Total Assets	2,145	1,362	2,229	3,134	3,144
Accounts Payable	229	121	213	332	386
Accrued Expenses	-	37	34	26	36
Current Portion of Leases	31	25	33	37	47
Other Current Liabilities	52	10	13	12	20
Total Current Liabilities	312	193	293	407	489
Long-Term Leases	64	-	27	-	37
Long-Term Deferred Tax Liabilities	5	-	22	53	18
Other Long-Term Liabilities	12	13	12	12	13
Total Liabilities	393	206	354	472	557
Common Stock	836	2,211	1,596	1,436	2,110
Additional Paid-In Capital	1,455	2,255	1,657	1,500	5,738
Retained Earnings	-521	-3,277	-1,336	-223	-5,204
Treasury Stock	-65	-65	-69	-70	-70
Comprehensive Income & Other	47	32	27	19	13
Shareholders' Equity	1,752	1,156	1,875	2,662	2,587
Total Liabilities & Equity	2,145	1,362	2,229	3,134	3,144
Total Debt	95	25	60	37	84
Net Cash (Debt)	1,292	861	668	766	630
Net Cash Growth	50.06%	28.89%	-12.79%	21.59%	-66.91%
Net Cash Per Share	5.44	4.33	3.97	5.04	4.84
Filing Date Shares Outstanding	263.3	218.05	173.94	167.97	133.54
Total Common Shares Outstanding	263.3	218.05	173.94	167.97	133.51
Working Capital	1,578	1,073	683	1,028	405
Book Value Per Share	6.65	5.30	10.78	15.85	19.38
Tangible Book Value	1,752	1,156	758	1,092	508
Tangible Book Value Per Share	6.65	5.30	4.36	6.50	3.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.